Evidence map›Paper›PMID 35225488›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2022

The Cytotoxic and Anti-Migratory Properties of Caesalpinia sappan and Ficus septica, in Combination with Doxorubicin on 4T1 TNBC Cells with Nephroprotective Potential.

Sari Haryanti, Ummi Maryam Zulfin, Irfani Aura Salsabila, Febri Wulandari, Edy Meiyanto

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Unlocking the therapeutic mechanism ofFrontiers in pharmacology · 2024
    Review
  3. Article
  4. Research in pharmaceutical sciences · 2023
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sari HaryantiMedicinal Plant and Traditional Medicine Research and Development Center, Tawangmangu, Central Java, Indonesia.
Ummi Maryam ZulfinCancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada (UGM), Yogyakarta, Indonesia.
Irfani Aura SalsabilaCancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada (UGM), Yogyakarta, Indonesia.
Febri WulandariCancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada (UGM), Yogyakarta, Indonesia.
Edy MeiyantoCancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada (UGM), Yogyakarta, Indonesia.ORCID 0000-0002-0886-6322
Siliwangi University · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the anti-cancer properties of Caesalpinia sappan and Ficus septica in combination with doxorubicin on 4T1 cells, confirm their nephroprotective activities, and predict the molecular targets of the underlying mechanisms.

methodsThe cytotoxic activities of all extracts and doxorubicin were determined by MTT assay followed by cell cycle and apoptosis analysis using flow cytometry. Immunoblotting was used to determine the protein expressions. The proteins involved in the cell proliferation and migration were analyzed through bioinformatics approaches, whereas, the interaction between compounds and protein targets was observed through molecular docking. Furthermore, the effect of the extracts on cell migration was analyzed by scratch wound healing assay. The intracellular ROS after treatment with extracts was observed using DCFDA staining flow cytometry.

resultsBoth ECS and EFS performed cytotoxic properties and significantly enhanced doxorubicin's cytotoxic effects against 4T1 cells. However, these cytotoxic activities did not correlate with the cell cycle progression. On the contrary, the combination treatment caused apoptosis that may correlate with the decreasing of IκBα phosphorylation, indicating that all agents targeted the inhibition of NF-κB activation. The combination treatments also inhibited cell migration and decreased MMP-9 expression. TNBC proliferation and metastasis needed at least 54 proteins to be activated, some of them are related to NF-κB activation. The inhibitory effect of ECS correlated with the interaction of brazilin and brazilein to IKK, a kinase protein that plays a role in IκBα phosphorylation. In addition, ECS and EFS reduced ROS expression in Vero cells caused by doxorubicin.

conclusionIn conclusion, ECS and EFS effectively enhanced the cytotoxic effect of doxorubicin and inhibit cell migration on 4T1 cells and these activities may correlate to the inhibitory effect of NF-κB activation. ECS and EFS also exhibit ROS suppressing effect on Vero cells that may be beneficent to reduce nephrotoxicity of chemotherapeutic treatment.

Indexed as

AnimalsApoptosisCaesalpiniaCell CycleCell Line, TumorCell MovementCell ProliferationChlorocebus aethiopsDoxorubicinDrug Therapy, CombinationFicusHumansPlant ExtractsProtective AgentsSignal TransductionVero CellsDoxorubicinPlant ExtractsProtective AgentsCaesalpinia sappancancer growth suppressionCytotoxic combination (co-treatment)Ficus septicakidney cytoprotective

Identifiers

PMID35225488
PMCPMC9272623
OpenAlexW4214513654

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.